The Washington Pharmacy Quality Assurance Commission (PQAC) issued updated guidance clarifying three pathways through which pharmacists may provide COVID-19 vaccinations: a statewide standing order, a Collaborative Drug Therapy Agreement (CDTA) or an individual prescription from another authorized practitioner. Under the statewide order, updated September 8, 2026, pharmacists may administer COVID-19 vaccines in accordance with state requirements and identify State Health Officer Dr. Kwan-Gett as the prescriber; alternatively, pharmacists may prescribe or order vaccines pursuant to a CDTA. The guidance confirms continued pharmacy-based access to COVID-19 vaccination while allowing pharmacies to select the authority best suited to their practice setting, recognizing pharmacists’ role in expanding convenient access to immunizations.

Also in Washington, PQAC is refining its accessible prescription labeling rules to expand exemptions and clarify when pharmacies and dispensing practitioners must provide accessible labeling services. They held a public hearing on the supplemental proposal on November 5.

Finally, in Washington, PQAC filed a rules proposal package (CR-102) under WSR 26-23-028 to amend WAC 246-945-043, updating and clarifying the list of designated nonnarcotic stimulant drugs without changing its substantive effect. A public hearing will be held on February 11, 2027, at 1:00 pm during its regularly scheduled business meeting. Comments on the proposed rules may be submitted to the DOH Rules Comment webpage or sent to Julia Katz-Ukropina, Program Consultant, at PharmacyRules@doh.wa.gov. Comments will be accepted until 11:59 pm on January 28, 2027.

For more information, contact NACDS’ Mary Staples at 817-442-1155.